Drug Research

Seqirus, a global leader in influenza prevention and a business of CSL Limited announced an investment in a new Research and Development (R&D) facility located in Waltham, Mass. The new facility will support the company’s growing R&D portfolio, with...

Piramal Pharma Limited’s Pharma Solutions business, a leading Contract Development and Manufacturing Organization (CDMO), announced the expansion of its Antibody-Drug Conjugate (ADC) capabilities at the Grangemouth facility in Scotland and the investment in new Active Pharmaceutical Ingredient (API) infrastructure...

DuPont has launched a new online sales portal tailored to the needs of bioprocessing industry purchasers. The portal handles online sales transactions, with target lead times of < 1 week. DuPont’s bioprocessing solutions enable sophisticated purifications and separations for therapeutics...

Cytiva, a global life sciences leader, and NecstGen, aim to accelerate the development of new cell and gene therapies globally via a strategic collaboration. Cytiva will provide its technologies, services, and solutions to NecstGen, and both organizations will share...

Biogen Inc. announced that it exercised its option to participate in the development and commercialization of mosunetuzumab. Biogen will pay a $30 million one-time option fee to Genentech, a member of the Roche Group, as part of the companies’...

Antiverse, a biotechnology company developing a computational antibody drug discovery platform, announced a partnership with a top 20 pharma company with core competencies in the life science fields of health care and nutrition. The collaboration has been successful in...

Cryoport, Inc., a global leader in temperature-controlled supply chain solutions for the life sciences industry, announced that it has entered into a strategic partnership with Cell Matters, S.A. to deliver to the life sciences industry end-to-end cryopreservation services for...